Search Results for "dabigatran"

Eur Rev Med Pharmacol Sci 2023; 27 (20): 10076-10081
DOI: 10.26355/eurrev_202310_34188

Utilization of direct oral anticoagulants in a Saudi tertiary hospital: a retrospective cohort study

H. Sultan, M. AlNasser, A. Assiri, F. Tawhari, A. Bakkari, M. Mustafa, W. Alotaibi, A. Asiri, A. Khudari, A. Alshreem, M. Ayoub, S. Alkhathami, H. Basndwah, O. Alsaeed, M. Alkredees, T. Alsalem, A. Alhuwail, T. Almalki, Y. Alzahrani, F. Alshahrani, B. Alqahtani, B. Alghamdi, A.R.N. Ibrahim, M. Zaitoun
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (20): 6245-6259
DOI: 10.26355/eurrev_202110_26994

Comparison between use of direct oral anticoagulants and aspirin for risk of thromboembolism complications in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis

J.-Y. Cai, C.-M. Cui, J.-K. Min, Y.-Q. Cao, L.-Y. Zhang
Free PDF Download

Eur Rev Med Pharmacol Sci 2021; 25 (13): 4499-4505
DOI: 10.26355/eurrev_202107_26241

Selecting the right anticoagulant for stroke prevention in atrial fibrillation

N.R. Kundnani, C.I. Rosca, A. Sharma, A. Tudor, M.S. Rosca, D.D. Nisulescu, H.S. Branea, V. Mocanu, D.C. Crisan, D.R. Buzas, S. Morariu, D.F. Lighezan
Free PDF Download

Eur Rev Med Pharmacol Sci 2018; 22 (15): 5042-5046
DOI: 10.26355/eurrev_201808_15647

Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®)

S. Hu, G. Belcaro, M. Dugall, P. Peterzan, M. Hosoi, A. Ledda, A. Riva, L. Giacomelli, S. Togni, R. Eggenhoffner4, R. Cotellese
Free PDF Download

Eur Rev Med Pharmacol Sci 2015; 19 (20): 3961-3967

Efficacy and safety of dabigatran in a “real-life” population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry

V. Russo, V. Bianchi, C. Cavallaro, F. Vecchione, S. De Vivo, L. Santangelo, B. Sarubbi, P. Calabrò, G. Nigro, A. D’Onofrio
Free PDF Download

Eur Rev Med Pharmacol Sci 2015; 19 (5): 897-903

Search Results for "dabigatran"

Utilization of direct oral anticoagulants in a Saudi tertiary hospital: a retrospective cohort study

Comparison between use of direct oral anticoagulants and aspirin for risk of thromboembolism complications in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis

Selecting the right anticoagulant for stroke prevention in atrial fibrillation

Interaction study between antiplatelet agents, anticoagulants, thyroid replacement therapy and a bioavailable formulation of curcumin (Meriva®)

Efficacy and safety of dabigatran in a “real-life” population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry

Dabigatran etexilate and LMWH for the prevention of venous thromboembolism in 532 patients undergoing hip surgery

Adverse skin reaction caused by dabigatran

Deep vein thrombosis and novel oral anticoagulants: a clinical review